(Q46069308)

19 December 2017

title

The effect of statins on the no-reflow phenomenon: an observational study in patients with hyperglycemia before primary angioplasty (English)

1 reference

19 December 2017

1 reference

1 reference

Jing-Lin Zhao

1

1 reference

19 December 2017

Yue-Jin Yang

2

1 reference

19 December 2017

Wei-Dong Pei

3

1 reference

19 December 2017

Yu-Hua Sun

4

1 reference

19 December 2017

Ji-Lin Chen

5

1 reference

19 December 2017

publication date

1 January 2009

1 reference

19 December 2017

American journal of cardiovascular drugs

published in

1 reference

19 December 2017

volume

9

1 reference

19 December 2017

issue

2

1 reference

19 December 2017

page(s)

81-89

1 reference

19 December 2017

https://scigraph.springernature.com/pub.10.1007/bf03256579

exact match

0 references

cites work

Primary percutaneous coronary intervention for every patient with ST-segment elevation myocardial infarction: what stands in the way?

1 reference

https://api.crossref.org/works/10.1007%2FBF03256579

Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256579

Predictors of in-hospital and 6-month outcome after acute myocardial infarction in the reperfusion era: the Primary Angioplasty in Myocardial Infarction (PAMI) trail

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256579

Association between hyperglycemia and the no-reflow phenomenon in patients with acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256579

Pretreatment with simvastatin reduces myocardial no-reflow by opening mitochondrial K(ATP) channel

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256579

Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256579

Impaired glucose metabolism predicts mortality after a myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256579

Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256579

Hyperglycaemia following acute myocardial infarction: the contribution of undiagnosed diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256579

Simvastatin and losartan enhance nitric oxide and reduce oxidative stress in salt-induced hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256579

HMG-CoA reductase inhibitors improve endothelial dysfunction in normocholesterolemic hypertension via reduced production of reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256579

Predictive factors for development of the no-reflow phenomenon in patients with reperfused anterior wall acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256579

Clinical and angiographic correlates and outcomes of suboptimal coronary flow inpatients with acute myocardial infarction undergoing primary percutaneous coronary intervention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256579

21 January 2018

Identifiers

DOI

10.1007/BF03256579

1 reference

19 December 2017

1 reference

19 December 2017